IMMUNOGENICITY OF FIMBRILLIN FROM B. GINGIVALIS
IMMUNOGENICITY OF FIMBRILLIN FROM B. GINGIVALIS
批准号:
3223211
负责人:
Patrick Michael Flood
金额:
$16.57万
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-04-01 至 1996-03-31
关键词:
Bacteroides gingivalis T cell receptor T lymphocyte antigen presenting cell bacterial antigens bacterial proteins cellular immunity enzyme linked immunosorbent assay genes helper T lymphocyte humoral immunity hybridomas immunogenetics in situ hybridization interferons interleukin 2 interleukin 4 laboratory mouse lymphokines major histocompatibility complex messenger RNA northern blottings peptides periodontium disorder pilus protein purification protein sequence synthetic peptide virulence western blottings
中文摘要
对细菌感染的特异性免疫反应已被证明是
包括产生定向的细胞和体液免疫
对抗细菌抗原。这些免疫效应器的激活
机制是通过诱导性T细胞与
免疫效应细胞,B细胞、T细胞或巨噬细胞。
严重的成人牙周病是一种疾病,其特征是
不能解决由病原体或病原体感染的
牙周边缘和牙周组织会导致慢性牙周炎
破坏性免疫反应。牙龈拟杆菌,黑色
色素性革兰氏阴性菌,已被认为是主要涉案细菌之一
严重成人牙周病的致病因素。这项建议
描述了研究T细胞的性质和特异性的研究
沙门氏菌菌毛的构成蛋白fimbrins对淋巴细胞的反应
牙龈假单胞菌381株。
T细胞识别抗原提呈细胞上的抗原为多肽
与主要组织相容性编码的自身分子相关
复杂。因此,整个BG、细菌菌毛或
将分析纯化的芬布林分子,以及影响Fimbrins分子的因素
比较了这些分子的免疫原性。小分子合成肽
将产生牙龈假单胞菌381菌株的芬布林分子
根据从克隆的fimbrins基因预测的氨基酸序列,
这些多肽将被分析以识别特定的氨基酸
芬布林分子上的酸序列,即表位,它能诱导
T淋巴细胞的免疫应答。T细胞反应的本质
将分析其对MHC连接的免疫表位的特异性
分子,其产生的炎性和体液淋巴因子,以及其
对BG、Fimbrae或fimbrins抗原的反应能力
不同的抗原提呈细胞。了解以下因素:
苯布林对免疫原性表位免疫应答的影响
显著提高我们对T细胞如何应对细菌的理解
体内的抗原,并将有助于设计更好的免疫学方法
到牙周病的治疗。
英文摘要
The specific immune response to bacterial infections have been shown to
involve the generation of both cellular and humoral immunity directed
against bacterial antigens. The activation of these immunologic effector
mechanisms is accomplished by the interaction of inducer T cells with
immunologic effector cells, either B cells, T cells, or macrophages.
Severe adult Periodontal disease is a disorder characterized by the
inability to resolve the infection by a pathogen or pathogens within the
gingival margins and the periodontium which results in a chronic
destructive immunologic response. Bacteroides Gingivalis, a black
pigmented gram negative bacteria, has been implicated as one of the major
causative agents in severe adult periodontal disease. This proposal
describes studies that investigate the nature and specificity of T
lymphocyte response to fimbrillin, the constitutive protein of fimbriae of
B. Gingivalis strain 381.
T cells recognize antigen on antigen-presenting cells as peptides
associated with self-molecules encoded by the Major Histocompatibility
Complex. Therefore, the immunogenicity of whole Bg, bacterial fimbrae, or
purified fimbrillin molecules will be analyzed, and factors influencing the
immunogenicity of these molecules compared. Small -synthetic peptides of
the fimbrillin molecule from B. Gingivalis strain 381 will be generated
based on the predicted amino acid sequence from the cloned fimbrillin gene,
and these peptides will be analyzed in order to identify specific amino
acid sequences, i.e. epitopes, on the fimbrillin molecule which induce
immunologic responses in T lymphocytes. The nature of the T cell response
to immunologic epitopes will be analyzed for its specificity for MHC-linked
molecules, its production of inflammatory and humoral lymphokines, and its
ability to respond to Bg, fimbrae, or fimbrillin antigen on a variety of
different antigen presenting cells. Understanding the factors which
influence the immune response to immunogenic epitopes on fimbrillin will
significantly enhance our understanding of how T cells respond to bacterial
antigens in .vivo, and will aid in designing better immunologic -approaches
to the treatment of periodontal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of IkK to treat lethal Graft-vs.-Host Disease
-
批准号:7883853
-
项目类别:
-
资助金额:$23.48万
-
财政年份:2009
-
负责人:Patrick Michael Flood
-
依托单位:
NF-kB Inhibition of Lung Ischemia Repurfusion Injury
-
批准号:7750074
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2009
-
负责人:Patrick Michael Flood
-
依托单位:
Blockade of NF-kappaB for Prevention/Treatment of GVHD
-
批准号:7108055
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2006
-
负责人:Patrick Michael Flood
-
依托单位:
Inhibition of IkK to treat lethal Graft-vs.-Host Disease
-
批准号:7481353
-
项目类别:
-
资助金额:$44.28万
-
财政年份:2006
-
负责人:Patrick Michael Flood
-
依托单位:
Inhibition of IkK to treat lethal Graft-vs.-Host Disease
-
批准号:7643877
-
项目类别:
-
资助金额:$45.44万
-
财政年份:2006
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6654111
-
项目类别:
-
资助金额:$13.82万
-
财政年份:2002
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6644959
-
项目类别:
-
资助金额:$13.82万
-
财政年份:2001
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6523867
-
项目类别:
-
资助金额:$227.41万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6175888
-
项目类别:
-
资助金额:$215.67万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6493982
-
项目类别:
-
资助金额:$13.82万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6199245
-
项目类别:
-
资助金额:$26.16万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:2800215
-
项目类别:
-
资助金额:$186.85万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6653937
-
项目类别:
-
资助金额:$233.23万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6643109
-
项目类别:
-
资助金额:$0.22万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6156412
-
项目类别:
-
资助金额:$16.38万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
COMPREHENSIVE CENTER FOR INFLAMMATORY DISORDERS
-
批准号:6379905
-
项目类别:
-
资助金额:$214.69万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6340857
-
项目类别:
-
资助金额:$19.97万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
ROLE OF NF-KB IN T CELL INFLAMMATION
-
批准号:6300948
-
项目类别:
-
资助金额:$11.68万
-
财政年份:1999
-
负责人:Patrick Michael Flood
-
依托单位:
DEVELOPMENT OF A CENTER FOR ORAL INFLAMMATORY DISORDERS
-
批准号:2395880
-
项目类别:
-
资助金额:$14.45万
-
财政年份:1997
-
负责人:Patrick Michael Flood
-
依托单位:
TC1 AND TC2 ACTIVITY IN MALIGNANCY
-
批准号:2115401
-
项目类别:
-
资助金额:$18.09万
-
财政年份:1996
-
负责人:Patrick Michael Flood
-
依托单位:
海外基金